J Am Acad Dermatol:前次非黑素瘤皮肤癌的成年人更容易实践防晒

2016-05-31 Mechront 译 MedSci原创

与既往无皮肤癌的患者相比,前次非黑素瘤皮肤癌的成年人更容易实践防晒。研究人员对758名前次非黑素瘤皮肤癌(NMSC)患者和34,161名非NMSC患者,受访者被问到他们在阴凉处呆多久,戴着一顶帽子遮住他们的脸、耳朵和脖子多长时间,穿长袖衬衫多长时间,如果外面的温暖,阳光灿烂超过1小时,他们是否使用防晒霜。前次NMSC与非NMSC相比,呆阴凉处(44.3% vs.27%)、长袖(20.5% vs.7

与既往无皮肤癌的患者相比,前次非黑素瘤皮肤癌的成年人更容易实践防晒。

研究人员对758名前次非黑素瘤皮肤癌(NMSC)患者和34,161名非NMSC患者,受访者被问到他们在阴凉处呆多久,戴着一顶帽子遮住他们的脸、耳朵和脖子多长时间,穿长袖衬衫多长时间,如果外面的温暖,阳光灿烂超过1小时,他们是否使用防晒霜。

前次NMSC与非NMSC相比,呆阴凉处(44.3% vs.27%)、长袖(20.5% vs.7.7%)、宽檐帽(26.1% vs. 10.5%)和防晒霜(53.7% vs.33.1%)的使用情况均更多。不过两组的近期晒伤差异不大(29.7% vs. 40.7%;aOR=0.95; 95% CI, 0.77-1.17)。

“前次NMSC患者的近期晒伤与年龄、阳光照射和不防晒的阴影呈反相关,”研究人员写道,并指出,几乎67%的18岁-39岁前次NMSC的患者是最近晒伤的人。

“我们的研究结果表明,随着年龄的增长晒伤的减少可能归因于太阳光下活动的减少,”研究人员写道。“医生应该继续强调防晒的重要性,尤其是年轻人。”

原始出处:

Fischer AH, et al. Sunburn and sun-protective behaviors among adults with and without previous nonmelanoma skin cancer (NMSC): A population-based study.J Am Acad Dermatol. 2016;doi:10.1016/j.jaad.2016.02.1236.

Adults with previous nonmelanoma skin cancer more likely to use sun protection, but still sunburn.Healio.May 25, 2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2034446, encodeId=6a6f2034446f5, content=<a href='/topic/show?id=d17499e79c8' target=_blank style='color:#2F92EE;'>#非黑素瘤皮肤癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99779, encryptionId=d17499e79c8, topicName=非黑素瘤皮肤癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Fri Oct 14 14:03:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651820, encodeId=5f03165182089, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Sat Dec 03 22:03:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479407, encodeId=fdb214e9407ae, content=<a href='/topic/show?id=4a571033209b' target=_blank style='color:#2F92EE;'>#黑素瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103320, encryptionId=4a571033209b, topicName=黑素瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d4d7523220, createdName=yuhaisheng_ibp_32061713, createdTime=Thu Jun 02 13:03:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88054, encodeId=667f88054db, content=多看看了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 15:37:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87979, encodeId=b5b18e9795a, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Jun 01 07:33:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87948, encodeId=9f338e94865, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87950, encodeId=4db68e9503d, content=已经收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2034446, encodeId=6a6f2034446f5, content=<a href='/topic/show?id=d17499e79c8' target=_blank style='color:#2F92EE;'>#非黑素瘤皮肤癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99779, encryptionId=d17499e79c8, topicName=非黑素瘤皮肤癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Fri Oct 14 14:03:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651820, encodeId=5f03165182089, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Sat Dec 03 22:03:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479407, encodeId=fdb214e9407ae, content=<a href='/topic/show?id=4a571033209b' target=_blank style='color:#2F92EE;'>#黑素瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103320, encryptionId=4a571033209b, topicName=黑素瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d4d7523220, createdName=yuhaisheng_ibp_32061713, createdTime=Thu Jun 02 13:03:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88054, encodeId=667f88054db, content=多看看了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 15:37:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87979, encodeId=b5b18e9795a, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Jun 01 07:33:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87948, encodeId=9f338e94865, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87950, encodeId=4db68e9503d, content=已经收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2016-12-03 lishizhe
  3. [GetPortalCommentsPageByObjectIdResponse(id=2034446, encodeId=6a6f2034446f5, content=<a href='/topic/show?id=d17499e79c8' target=_blank style='color:#2F92EE;'>#非黑素瘤皮肤癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99779, encryptionId=d17499e79c8, topicName=非黑素瘤皮肤癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Fri Oct 14 14:03:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651820, encodeId=5f03165182089, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Sat Dec 03 22:03:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479407, encodeId=fdb214e9407ae, content=<a href='/topic/show?id=4a571033209b' target=_blank style='color:#2F92EE;'>#黑素瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103320, encryptionId=4a571033209b, topicName=黑素瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d4d7523220, createdName=yuhaisheng_ibp_32061713, createdTime=Thu Jun 02 13:03:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88054, encodeId=667f88054db, content=多看看了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 15:37:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87979, encodeId=b5b18e9795a, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Jun 01 07:33:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87948, encodeId=9f338e94865, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87950, encodeId=4db68e9503d, content=已经收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2034446, encodeId=6a6f2034446f5, content=<a href='/topic/show?id=d17499e79c8' target=_blank style='color:#2F92EE;'>#非黑素瘤皮肤癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99779, encryptionId=d17499e79c8, topicName=非黑素瘤皮肤癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Fri Oct 14 14:03:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651820, encodeId=5f03165182089, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Sat Dec 03 22:03:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479407, encodeId=fdb214e9407ae, content=<a href='/topic/show?id=4a571033209b' target=_blank style='color:#2F92EE;'>#黑素瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103320, encryptionId=4a571033209b, topicName=黑素瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d4d7523220, createdName=yuhaisheng_ibp_32061713, createdTime=Thu Jun 02 13:03:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88054, encodeId=667f88054db, content=多看看了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 15:37:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87979, encodeId=b5b18e9795a, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Jun 01 07:33:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87948, encodeId=9f338e94865, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87950, encodeId=4db68e9503d, content=已经收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2016-06-01 沉心多思

    多看看了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2034446, encodeId=6a6f2034446f5, content=<a href='/topic/show?id=d17499e79c8' target=_blank style='color:#2F92EE;'>#非黑素瘤皮肤癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99779, encryptionId=d17499e79c8, topicName=非黑素瘤皮肤癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Fri Oct 14 14:03:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651820, encodeId=5f03165182089, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Sat Dec 03 22:03:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479407, encodeId=fdb214e9407ae, content=<a href='/topic/show?id=4a571033209b' target=_blank style='color:#2F92EE;'>#黑素瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103320, encryptionId=4a571033209b, topicName=黑素瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d4d7523220, createdName=yuhaisheng_ibp_32061713, createdTime=Thu Jun 02 13:03:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88054, encodeId=667f88054db, content=多看看了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 15:37:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87979, encodeId=b5b18e9795a, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Jun 01 07:33:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87948, encodeId=9f338e94865, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87950, encodeId=4db68e9503d, content=已经收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2016-06-01 1dd8c52fm63(暂无匿称)

    了解一下!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2034446, encodeId=6a6f2034446f5, content=<a href='/topic/show?id=d17499e79c8' target=_blank style='color:#2F92EE;'>#非黑素瘤皮肤癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99779, encryptionId=d17499e79c8, topicName=非黑素瘤皮肤癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Fri Oct 14 14:03:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651820, encodeId=5f03165182089, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Sat Dec 03 22:03:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479407, encodeId=fdb214e9407ae, content=<a href='/topic/show?id=4a571033209b' target=_blank style='color:#2F92EE;'>#黑素瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103320, encryptionId=4a571033209b, topicName=黑素瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d4d7523220, createdName=yuhaisheng_ibp_32061713, createdTime=Thu Jun 02 13:03:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88054, encodeId=667f88054db, content=多看看了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 15:37:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87979, encodeId=b5b18e9795a, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Jun 01 07:33:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87948, encodeId=9f338e94865, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87950, encodeId=4db68e9503d, content=已经收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2016-06-01 milkshark

    值得学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2034446, encodeId=6a6f2034446f5, content=<a href='/topic/show?id=d17499e79c8' target=_blank style='color:#2F92EE;'>#非黑素瘤皮肤癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99779, encryptionId=d17499e79c8, topicName=非黑素瘤皮肤癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Fri Oct 14 14:03:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651820, encodeId=5f03165182089, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Sat Dec 03 22:03:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479407, encodeId=fdb214e9407ae, content=<a href='/topic/show?id=4a571033209b' target=_blank style='color:#2F92EE;'>#黑素瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103320, encryptionId=4a571033209b, topicName=黑素瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d4d7523220, createdName=yuhaisheng_ibp_32061713, createdTime=Thu Jun 02 13:03:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88054, encodeId=667f88054db, content=多看看了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 15:37:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87979, encodeId=b5b18e9795a, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Jun 01 07:33:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87948, encodeId=9f338e94865, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87950, encodeId=4db68e9503d, content=已经收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Wed Jun 01 06:41:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2016-06-01 milkshark

    已经收藏

    0

相关资讯

河南省肿瘤医院切除百岁老人面部皮肤癌

白冰/图“人们都说:大难不死必有后福。俺妈以后享福的日子还长着了。”说这话的,是周口市年过六旬的杨老汉,他的母亲高老太太今年99岁,按照习俗要过百岁大寿的。就在不久前,她在河南省肿瘤医院头颈甲状腺外科的病房里度过了百岁生日。 两年前,97岁的高老太太发现,自己上唇左侧皮肤上长出一肿块,并伴有局部的瘙痒,于是她不自觉的搔抓,可肿物缓慢增大,还出现了局部的破溃肿胀。最终在当地医院就诊,进行了

Free Radical Biology and Medicine:天然食品添加剂胭脂树橙可预防皮肤癌

亚利桑那大学药学院的研究人员发现,天然食品添加剂中的一种化合物——胭脂树橙,可以防止小鼠癌细胞的形成和紫外线对皮肤的损伤。胭脂树橙是橙红色化合物,主要存在于红木、天然调味品和食品着色的胭脂树果实的种子;是拉丁美洲烹饪的常见成分。wondrak博士的实验室致力于找到食物中可以预防皮肤癌的小分子。张博士Nrf2转录因子领域的专家,该基因可以加强细胞对抗致癌物。wondrak博士偶尔间发现了胭脂树橙可以

验血能为皮肤癌的复发提供早期预警

3月7日发表在《癌症探索》上的一篇文章报道,一项血液检查可能为晚期黑色素瘤的复发提供早期预警。 英国曼彻斯特癌症研究所的科学家们研究了7名英国国家医疗服务系统基金会的晚期黑色素瘤患者血样中的循环肿瘤DNA,即肿瘤脱落在血液中的DNA。研究前期,他们发现通过跟踪血液中循环肿瘤DNA的水平就可预测患者是否有复发。此外,还发现NRAS和PI3K等基因中新的突变可能就是肿瘤复发的原因,因为这些突变使肿瘤

J Intern Med:不晒太阳就像吸烟一样有害!

典型的不良生活习惯有仨:吸烟、肥胖、不运动,现在多了第四个:不晒太阳。

体外诊断可监测皮肤癌的复发

通过对癌症患者进行血液检测,可以监测晚期黑色素瘤皮肤癌患者在治疗期间癌症的复发情况。 来自英国曼彻斯特癌症研究所的科研工作人员,通过对七个晚期黑色素瘤患者血液样品中循环肿瘤DNA(circulating tumor DNA)进行检测研究分析。他们的研究结果证明可以通过跟踪CtDNA在血液的水平,来判断癌症的复发。 另外,科研人员还发现,如果检测到NRAS和PI3K等基因发生突变,在癌症治疗

Cancer Cell:HIV药物有望阻止皮肤癌产生耐药性

在一项新的获得英国癌症研究中心资助的研究中,来自英国曼彻斯特大学等多个机构的研究人员发现一种抗HIV药物能够阻止皮肤癌细胞早期基因变化中的一种导致它们对药物治疗产生耐药性的变化。相关研究结果发表在2016年3月14日那期Cancer Cell期刊上,论文标题为“Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage St